Quantitation of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: Preliminary report from an ongoing trial

European Journal of Cancer

Volumn 31, Issue 7-8, 1995, Pages 1306-1310

  Leichman, L ^a   Lenz, H J ^a   Leichman, C G ^a   Groshen, S ^a   Danenberg, K ^b   Baranda, J ^a   Spears, C P ^a   Boswell, W ^a   Silberman, H ^a   Ortega, A ^a   Stain, S ^a   Beart, R ^a   Danenberg, P ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b the Department of Biochemistry University of Southern California ^*

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; FLUOROURACIL; FOLINIC ACID; THYMIDYLATE SYNTHASE;

ADULT; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; DRUG RESISTANCE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVIEW;

ADULT; AGED; AGED, 80 AND OVER; ANTIDOTES; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BASE SEQUENCE; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; GENE EXPRESSION; HUMAN; LEUCOVORIN; MALE; MIDDLE AGE; MOLECULAR SEQUENCE DATA; SUPPORT, U.S. GOV'T, P.H.S.; THYMIDYLATE SYNTHASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0029095796     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00326-E     Document Type: Article

References (28)

1. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma
2. A randomized phase I and II study of short-term infusion of high dose fluorouracil with or without n-(phosphonacetyl)-l-aspartic acid in patients with advanced pancreatic and colorectal cancers
3. Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma
4. Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil
5. Relationship of dUMP and free FdUMP pools to inhibition of thymidylate synthase by 5-fluorouracil
6. Folinic acid augmentation of the effects of fluoropyrimidines on murine and human leukemic cells
7. In vivo kinetics of thymidylate synthase inhibition in 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas
8. Biochemical and molecular properties of cisplatin-resistant A2780 cells grown in folinic acid
9. Thymidylate synthase levels as a factor in 5-fluorodeoxyuridine and methotrexate cytotoxicity in gastrointestinal tumor cells
10. Thymidylate synthase overproduction and gene amplification in fluorodeoxyuridine-resistant human cells
11. Fluorouracil and high dose leucovorin in previously treated patients with metastatic breast cancer
12. Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines
13. Thymidylate synthase from untreated human colorectal cancer and colonic mucosa: enzyme activity and inhibition by 5-fluoro-2′-deoxy-uridine-5′-monophosphate
14. Salvage therapy of breast cancer with fluorouracil (5-FU) and high-dose leucovorin (LV): response correlations with tumor pharmacodynamics
15. The polymerase chain reaction: a new method of using molecular genetics for medical diagnosis
16. Unstable methotrexate resistance in human small cell carcinoma associated with double minute chromosomes
17. Quantitation of thymidylate synthase, dihydrofolate reductase and DT-diaphorase gene expression in human tumors using the polymerase chain reaction
18. Prolonged continuous infusion of fluorouracil with weekly bolus leucovorin: a phase II study of patients with colorectal cancer
19. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
20. Nucleotide sequence of a functional cDNA for human thymidylate synthase
21. Evolution of the functional human β-actin gene and its multipseudogene family: conservation of noncoding regions and chromosomal dispersion of pseudogenes
22. Fluorouracil (5-FU) schedules and modulation in advanced colorectal cancer (CRC): a Southwest Oncology Group (SWOG) screening trial
23. Maximally selected chi square statistics
24. Maximally selected chi square statistics for small samples
25. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma
26. Prolongation of the diseasefree interval in surgically treated rectal carcinoma
27. Thymidylate synthase expression is an independent predictor of survival/disease freesurvival in patients with rectal cancer